Our data refer to an in vitro exploration on cellular models of NB, a solid tumor known to have dysfunctional p53 (61) and to be able to evade NK cell-mediate immunosurveillance through down-regulation of ligands for NK cell activating-receptors (26, 38, 62, 63). The gene discussed is TP53; the disease is neuroblastoma.